| Literature DB >> 33489140 |
Riccardo Bruna1, Riccardo Moia1, Alessandra Valpreda2, Enrico Dosio2, Roberta Rolla3, Augusto Federici4, Umberto Dianzani3, Gianluca Gaidano1, Andrea Patriarca1.
Abstract
This case report highlights the challenges in controlling bleeding and correcting coagulation tests through the use of bypassing agents in patients with FV inhibitors.Entities:
Keywords: acquired hemophilia; bypassing agents; factor V inhibitor
Year: 2020 PMID: 33489140 PMCID: PMC7813060 DOI: 10.1002/ccr3.3452
Source DB: PubMed Journal: Clin Case Rep ISSN: 2050-0904